Drug Information
Drug (ID: DG01484) and It's Reported Resistant Information
Name |
Amrubicin
|
||||
---|---|---|---|---|---|
Synonyms |
Amrubicin; 110267-81-7; UNII-93N13LB4Z2; C25H25NO9; 93N13LB4Z2; (+-)-(7S,9S)-9-Acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione; (7S,9S)-9-acetyl-9-amino-7-(((2S,4S,5R)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Amrubicin [USAN:INN]; amrubicina; amrubicine; amrubicinum; Amrubicin Api; (7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; (7S,9S)-9-acetyl-9-amino-7-{[(2S,4S,5R)-4,5-dihydroxytetrahydro-2H-pyran-2-yl]oxy}-6,11-dihydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Amrubicin (USAN/INN); Amrubicin(SM-5887); SCHEMBL9140; CHEMBL1186894; EX-A161; CHEBI:135779; HY-B0067; ZINC3780800; 3441AH; DB06263; LS41109; AC-31129; D08854; W-60403; Q4748723; W-200813; (1S,3S)-3-acetyl-3-amino-5,12-dihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2-deoxy-beta-D-erythro-pentopyranoside; 5,12-Naphthacenedione, 9-acetyl-9-amino-7-((2-deoxy-beta-D-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-, (7S,9S)-
Click to Show/Hide
|
||||
Indication |
In total 1 Indication(s)
|
||||
Structure | |||||
Target | . | NOUNIPROTAC | [1] | ||
Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
Formula |
3
|
||||
IsoSMILES |
CC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)O[C@H]5C[C@@H]([C@@H](CO5)O)O)N
|
||||
InChI |
InChI=1S/C25H25NO9/c1-10(27)25(26)7-13-18(16(8-25)35-17-6-14(28)15(29)9-34-17)24(33)20-19(23(13)32)21(30)11-4-2-3-5-12(11)22(20)31/h2-5,14-17,28-29,32-33H,6-9,26H2,1H3/t14-,15+,16-,17-,25-/m0/s1
|
||||
InChIKey |
VJZITPJGSQKZMX-XDPRQOKASA-N
|
||||
PubChem CID | |||||
ChEBI ID | |||||
TTD Drug ID | |||||
DrugBank ID |
Type(s) of Resistant Mechanism of This Drug
UAPP: Unusual Activation of Pro-survival Pathway
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-02: Benign/in-situ/malignant neoplasm
Lung cancer [ICD-11: 2C25]
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Unusual Activation of Pro-survival Pathway (UAPP) | ||||
Key Molecule: Quinone reductase 1 (NQO1) | [1] | |||
Molecule Alteration | Missense mutation | p.P187S (c.559C>T) |
||
Sensitive Disease | Lung adenocarcinoma [ICD-11: 2C25.0] | |||
Experimental Note | Revealed Based on the Cell Line Data | |||
In Vitro Model | A549 cells | Lung | Homo sapiens (Human) | CVCL_0023 |
NCI-H69 cells | Lung | Homo sapiens (Human) | CVCL_1579 | |
NCI-H460 cells | Lung | Homo sapiens (Human) | CVCL_0459 | |
NCI-H23 cells | Lung | Homo sapiens (Human) | CVCL_1547 | |
PC-1 cells | Pancreas | Homo sapiens (Human) | CVCL_S978 | |
PC-10 cells | Lung | Homo sapiens (Human) | CVCL_7088 | |
QG56 cells | Lung | Homo sapiens (Human) | CVCL_6943 | |
RERF-LC-MT cells | Lung | Homo sapiens (Human) | CVCL_A473 | |
Sk-LC-6 cells | Lung | Homo sapiens (Human) | CVCL_5474 | |
PC9 cells | Lung | Homo sapiens (Human) | CVCL_B260 | |
SK-LC-2 cells | Lung | Homo sapiens (Human) | CVCL_5468 | |
SK-LC-17 cells | Lung | Homo sapiens (Human) | CVCL_5466 | |
SK-LC-1 cells | Lung | Homo sapiens (Human) | CVCL_5458 | |
SBC3 cells | Bone marrow | Homo sapiens (Human) | CVCL_1678 | |
RERF-LC-OK cells | Central nervous system | Homo sapiens (Human) | CVCL_3154 | |
RERF-LC-MS cells | Lung | Homo sapiens (Human) | CVCL_1655 | |
PC6 cells | Adrenal gland | Rattus norvegicus (Rat) | CVCL_7091 | |
NCI-H417 cells | Lung | Homo sapiens (Human) | CVCL_1602 | |
NCI-H1688 cells | Liver | Homo sapiens (Human) | CVCL_1487 | |
DMS53 cells | Lung | Homo sapiens (Human) | CVCL_1177 | |
ACC-LC-94 cells | Lung | Homo sapiens (Human) | CVCL_7032 | |
ACC-LC-80 cells | Lymph node | Homo sapiens (Human) | CVCL_7028 | |
ACC-LC-73 cells | Lung | Homo sapiens (Human) | CVCL_7026 | |
ACC-LC-67 cells | Lymph node | Homo sapiens (Human) | CVCL_7024 | |
ACC-LC-5 cells | Cervical lymph node | Homo sapiens (Human) | CVCL_7020 | |
ACC-LC-48 cells | Pericardial effusion | Homo sapiens (Human) | CVCL_7018 | |
ACC-LC-314 cells | Lung | Homo sapiens (Human) | CVCL_7011 | |
ACC-LC-174 cells | Lung | Homo sapiens (Human) | CVCL_7007 | |
ACC-LC-172 cells | Pericardial effusion | Homo sapiens (Human) | CVCL_7005 | |
Experiment for Molecule Alteration |
Western blotting analysis | |||
Experiment for Drug Resistance |
CellTiter 96 AQueous One assay | |||
Mechanism Description | The missense mutation p.P187S (c.559C>T) in gene NQO1 cause the sensitivity of Amrubicin by unusual activation of pro-survival pathway |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.